Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/20872225
Conclusion of this study
Both dosages of Pueraria mirifica were similarly effective and safe in the treatment of menopausal symptoms.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
Functions related to this study
|
||
|
Body systems related to this study
Reproductive System |